guanfacine has been researched along with Cannabis Abuse in 2 studies
Guanfacine: A centrally acting antihypertensive agent with specificity towards ADRENERGIC ALPHA-2 RECEPTORS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Guanfacine was well tolerated with little evidence of fatigue and only small decreases in blood pressure: no dose was held due to hypotension." | 1.51 | Guanfacine decreases symptoms of cannabis withdrawal in daily cannabis smokers. ( Bedi, G; Comer, SD; Cooper, ZD; Foltin, RW; Haney, M; Herrmann, E; Levin, FR; Reed, SC, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haney, M | 1 |
| Cooper, ZD | 1 |
| Bedi, G | 1 |
| Herrmann, E | 1 |
| Comer, SD | 1 |
| Reed, SC | 1 |
| Foltin, RW | 1 |
| Levin, FR | 2 |
| Dakwar, E | 1 |
| Mahony, A | 1 |
| Choi, CJ | 1 |
| Pavlicova, M | 1 |
| Brooks, D | 1 |
| Mariani, JP | 1 |
1 trial available for guanfacine and Cannabis Abuse
| Article | Year |
|---|---|
Guanfacine extended-release for cannabis use disorder: a pilot feasibility trial.
Topics: Adrenergic alpha-2 Receptor Agonists; Adult; Delayed-Action Preparations; Feasibility Studies; Femal | 2020 |
1 other study available for guanfacine and Cannabis Abuse
| Article | Year |
|---|---|
Guanfacine decreases symptoms of cannabis withdrawal in daily cannabis smokers.
Topics: Adrenergic alpha-2 Receptor Agonists; Adult; Affect; Anorexia; Blood Pressure; Cannabis; Feeding Beh | 2019 |